enGene Therapeutics Inc. (ENGN)
Biological Products, (No Diagnostic Substances) · Healthcare · $3.1B
Intrinsic Value (Consensus)
$26.46
Current Price
$45.80
Margin of Safety
-42.2%
42.2% Above Intrinsic Value
Value: $26
Price: $46
Valuation Model Estimates
Current Price: $45.80
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
$11.36
Earnings Power Value
$22.23
Relative Value (P/E)
$45.80
Dividend Discount Model
Not applicable
—
Consensus Value
$26.46
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $2.29
- EPS (Forward)
- $2.75
- Book Value
- $2.50
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- -69.9%
- Debt/Equity
- —
- Revenue Growth
- N/A
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Data last updated: 2026-06-12
Source: Yahoo Finance